Evidence map›Paper›PMID 39918122›Full record

SynthesisThe Cochrane database of systematic reviews2025

Prognostic value of blood eosinophils for predicting survival and treatment outcomes in people with non-small cell lung cancer.

Hugues Sultana, Tom De Vos, Reem Malouf, François Calais, Corynne Marchal, Guillaume Eberst, Virginie Westeel, Cindy Barnig

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hugues SultanaChest Disease Department, University Hospital, Besançon, France.
Tom De VosChest Disease Department, University Hospital, Besançon, France.
Reem MaloufNuffield Department of Population Health, Big Data Institute (BDI), University of Oxford, Oxford, UK.
François CalaisHealth Sciences University Library, Marie & Louis Pasteur University, Besançon, France.
Corynne MarchalMarie & Louis Pasteur University, Besançon, France.
Guillaume EberstChest Disease Department, University Hospital, Besançon, France.
Virginie WesteelChest Disease Department, University Hospital, Besançon, France.
Cindy BarnigChest Disease Department, University Hospital, Besançon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane Review (prognosis). The objectives are as follows: To assess the prognostic value of measuring pretreatment baseline blood eosinophil levels in adults receiving systemic treatment for any stage of non-small cell lung cancer.

Indexed as

Carcinoma, Non-Small-Cell LungEosinophilsLung NeoplasmsAdultHumansLeukocyte CountPrognosisRandomized Controlled Trials as Topic

Identifiers

PMID39918122
PMCPMC11803715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.